Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-25

Clinical Trial Update: Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)

View source ↗

Summary

The document reports cost-utility analyses evaluating adalimumab treatment in rheumatoid arthritis, presenting economic results derived from completed trial dat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2011-07-25